These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37345586)

  • 1. FGF19-Induced Inflammatory CAF Promoted Neutrophil Extracellular Trap Formation in the Liver Metastasis of Colorectal Cancer.
    Li C; Chen T; Liu J; Wang Y; Zhang C; Guo L; Shi D; Zhang T; Wang X; Li J
    Adv Sci (Weinh); 2023 Aug; 10(24):e2302613. PubMed ID: 37345586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.
    Zhao S; Mi Y; Zheng B; Wei P; Gu Y; Zhang Z; Xu Y; Cai S; Li X; Li D
    J Extracell Vesicles; 2022 Jan; 11(1):e12186. PubMed ID: 35041299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.
    Chen X; Chen J; Feng W; Huang W; Wang G; Sun M; Luo X; Wang Y; Nie Y; Fan D; Wu K; Xia L
    Theranostics; 2023; 13(4):1401-1418. PubMed ID: 36923538
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishment of a neutrophil extracellular trap-related prognostic signature for colorectal cancer liver metastasis and expression validation of CYP4F3.
    Tang XL; Xu ZY; Guan J; Yao J; Tang XL; Zhou ZQ; Zhang ZY
    Clin Exp Med; 2024 May; 24(1):112. PubMed ID: 38795162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.
    Tiong KH; Tan BS; Choo HL; Chung FF; Hii LW; Tan SH; Khor NT; Wong SF; See SJ; Tan YF; Rosli R; Cheong SK; Leong CO
    Oncotarget; 2016 Sep; 7(36):57633-57650. PubMed ID: 27192118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
    Kim RD; Sarker D; Meyer T; Yau T; Macarulla T; Park JW; Choo SP; Hollebecque A; Sung MW; Lim HY; Mazzaferro V; Trojan J; Zhu AX; Yoon JH; Sharma S; Lin ZZ; Chan SL; Faivre S; Feun LG; Yen CJ; Dufour JF; Palmer DH; Llovet JM; Manoogian M; Tugnait M; Stransky N; Hagel M; Kohl NE; Lengauer C; Sherwin CA; Schmidt-Kittler O; Hoeflich KP; Shi H; Wolf BB; Kang YK
    Cancer Discov; 2019 Dec; 9(12):1696-1707. PubMed ID: 31575541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3.
    Li X; Wang Z; Jiao C; Zhang Y; Xia N; Yu W; Chen X; Wikana LP; Liu Y; Sun L; Chen M; Xiao Y; Shi Y; Han S; Pu L
    J Transl Med; 2023 Feb; 21(1):121. PubMed ID: 36788538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4.
    Chen J; Du F; Dang Y; Li X; Qian M; Feng W; Qiao C; Fan D; Nie Y; Wu K; Xia L
    Hepatology; 2020 May; 71(5):1712-1731. PubMed ID: 31529503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1
    Zhou J; Song Q; Li H; Han Y; Pu Y; Li L; Rong W; Liu X; Wang Z; Sun J; Song Y; Hu X; Zhu G; Zhu H; Yang L; Ge G; Li H; Ji Q
    Mol Cancer; 2024 Aug; 23(1):168. PubMed ID: 39164758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis.
    Lang L; Xiong Y; Prieto-Dominguez N; Loveless R; Jensen C; Shay C; Teng Y
    J Exp Clin Cancer Res; 2021 Mar; 40(1):93. PubMed ID: 33691750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF19/SOCE/NFATc2 signaling circuit facilitates the self-renewal of liver cancer stem cells.
    Wang J; Zhao H; Zheng L; Zhou Y; Wu L; Xu Y; Zhang X; Yan G; Sheng H; Xin R; Jiang L; Lei J; Zhang J; Chen Y; Peng J; Chen Q; Yang S; Yu K; Li D; Xie Q; Li Y
    Theranostics; 2021; 11(10):5045-5060. PubMed ID: 33754043
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization.
    Shen L; Wang C; Ren R; Liu X; Zhou D; Chen Y; Zhou Y; Lei J; Xiao Y; Zhang N; Zhao H; Li Y
    Inflamm Res; 2024 Sep; 73(9):1493-1510. PubMed ID: 38981913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.
    Xie M; Lin Z; Ji X; Luo X; Zhang Z; Sun M; Chen X; Zhang B; Liang H; Liu D; Feng Y; Wang Y; Li Y; Liu B; Huang W; Xia L
    J Hepatol; 2023 Jul; 79(1):109-125. PubMed ID: 36907560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.
    Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
    Oncotarget; 2016 Mar; 7(12):13575-86. PubMed ID: 26498355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
    Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
    Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Hu L; Cong L
    Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
    Xiao Y; Cong M; Li J; He D; Wu Q; Tian P; Wang Y; Yang S; Liang C; Liang Y; Wen J; Liu Y; Luo W; Lv X; He Y; Cheng DD; Zhou T; Zhao W; Zhang P; Zhang X; Xiao Y; Qian Y; Wang H; Gao Q; Yang QC; Yang Q; Hu G
    Cancer Cell; 2021 Mar; 39(3):423-437.e7. PubMed ID: 33450198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling.
    Teng Y; Zhao H; Gao L; Zhang W; Shull AY; Shay C
    Cancer Res; 2017 Nov; 77(22):6215-6225. PubMed ID: 28951455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling.
    Tian S; Chen M; Wang B; Han Y; Shang H; Chen J
    Ann Hepatol; 2021; 20():100259. PubMed ID: 32980439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling.
    Wu S; Ye S; Lin X; Chen Y; Zhang Y; Jing Z; Liu W; Chen W; Lin X; Lin X
    Cancer Lett; 2021 Feb; 499():175-187. PubMed ID: 33249195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.